Virax Biolabs Group Ltd (VRAX) Gross margin 2021–2025
Virax Biolabs Group Ltd (VRAX) gross margin by fiscal year — reported gross profit divided by reported revenue.
-838.2%FY2025 · since FY2021: -7.6% → -838.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -838.2% | -870.6 pp |
| FY2024 | 32.3% | +48.3 pp |
| FY2023 | -15.9% | — |
| FY2021 | -7.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX RevenueVRAX Net incomeVRAX Net marginVRAX Gross profitVRAX Operating incomeVRAX Operating marginVRAX Operating cash flowVRAX Free cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Total liabilitiesVRAX Shareholders’ equityVRAX overview →